Paul Navarre - Articles and news items

Allergan’s BOTOX® (botulinum toxin type A) receives national marketing authorisation for treatment of moderate to severe crow’s feet lines in adult patients

Industry news / 9 January 2014 / Allergan

New aesthetic indication for market-leading neuromodulator which can now help improve appearance of lines around the eyes, as well as treating glabellar frown lines…

Allergan’s VISTABEL® (botulinum toxin type A) Receives Europe’s First Positive Opinion for Treatment of Moderate to Severe Lateral Canthal Lines (Crow’s Feet Lines) in Adult Patients

Industry news / 23 October 2013 / Chandler Chicco Agency

Positive opinion paves the way for a second aesthetic indication for VISTABEL® in 29 European countries…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+